サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：ニパウイルス感染検査の世界市場：2023-2030年
市場調査レポート
商品コード
1380261

ニパウイルス感染検査の世界市場：2023-2030年

Global Nipah Virus Infection Testing Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 225 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
ニパウイルス感染検査の世界市場：2023-2030年
出版日: 2023年09月26日
発行: Orion Market Research
ページ情報: 英文 225 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のニパウイルス感染検査市場は予測期間（2023-2030年）にCAGR 4.8％で成長すると予測されます。市場の成長は、世界中でニパウイルス感染症の発生率が増加していることに起因しています。ニパウイルスは、感染した動物（ブタやコウモリなど）やその体液から、接触を通じて個人に感染します。血液、尿、唾液などの体液が関与します。国立衛生研究所によると、2023年3月、脳炎とNiV感染は関連している（脳の炎症）。感染後、5日から14日間、発熱と頭痛が3日から14日間続く。その後、無気力、見当識障害、錯乱が続くことがあります。24～48時間以内に、これらの徴候や症状が昏睡状態にまで進行することもあります。感染初期には呼吸器系に異常をきたす人もおり、重篤な神経症状を呈した人の50％は肺症状も併発していました。NiVの感染は、ブタやコウモリなどの感染動物やその体液（唾液、尿、血液など）との接触によって起こる可能性があります。最初に記録されたNiVの集団発生では、人々は病気の豚との密接な接触によってウイルスに感染しました。このアウトブレイクで発見されたNiV株は、最初はコウモリの間で広がり、次にブタに広がり、最終的にブタの集団に広がったようです。

セグメント別の展望

ELISAキットのサブセグメントが世界のニパウイルス感染検査市場に大きく寄与すると予測される

検査タイプのうち、ELISAキットのサブセグメントが世界のニパウイルス感染検査市場でかなりのシェアを占めると予想されます。このセグメントの成長は、ELISA検査の採用が増加していることに起因しています。ELISAがニパウイルス検出のための実行可能な技術であることが証明されたため、臨床および公衆衛生環境における検査の使用が拡大する可能性があります。ELISAのような経済的で効果的な診断技術は、大規模な疫学調査に利用することができます。2022年9月の国立衛生研究所（National Institute of Health（gov.））によると、ELISAは大規模な疫学調査においてニパウイルスの検出に使用できる、効果的で安全かつコスト効率の高い診断ツールです。IgMおよびIgG ELISA検査はまた、公衆衛生上の介入を知らせるのにも役立ちます。さらに、米国疾病予防管理センター（CDC）の基準検査との比較において、開発された抗ニパウイルスIgMおよびIgG ELISAは99.28%の特異性と100%の感度を示しました。抗ニパIgMおよびIgG ELISA法は、陰性的中率100％、陽性的中率90％および93.94％を示し、検査精度は99.33％でした。

地域的展望

世界のニパウイルス感染検査市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、中南米）を含む地域別にさらに細分化されています。

ニパウイルス感染検査の世界市場ではアジア太平洋地域が大幅なCAGRで成長する見込み

すべての地域の中で、アジア太平洋地域は予測期間中にかなりのCAGRで成長すると予測されています。この地域の成長は、検査需要の増加に起因しています。ケララ州で報告された症例は、ニパウイルスに対する正確で広く利用可能な診断手順を持つことの重要性を強調しています。診断、接触者追跡、疫病管理のための検査は、症例が確認された後にすべて必要となります。

世界保健機関（WHO）によると、2023年10月、9月12日以降、387検体の検査が行われ、ニパウイルス感染陽性例が6例、陰性例が381例となっています。さらに、ケララ州政府によれば、2023年9月12日から9月15日の間に、2人の死亡例を含む6人のニパウイルス感染症例が実験室で確認されました。ケララ州コジコデ地区で確認されたすべての事例で、9歳から45歳までの男性が感染していました。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近の動向
  • 主要戦略分析

第4章 市場セグメンテーション

  • ニパウイルス感染検査の世界市場：検査タイプ別
    • RT PCRベースのキット
    • ELISAキット
  • ニパウイルス感染検査の世界市場：検体タイプ別
    • 血清または血漿
    • 唾液および咽頭スワブ
    • 尿
    • その他（脳脊髄液（CSF）、呼吸器分泌液、環境サンプル）
  • ニパウイルス感染検査の世界市場：エンドユーザー別
    • 病院
    • 研究機関
    • 診断センター
    • その他（非政府組織（NGO）、緊急対応チーム、公衆衛生当局）

第5章 地域分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • Creative Biogene.
  • Creative Diagnostics
  • Indian Council of Medical Research-National Institute of Virus
  • Jiangsu Bioperfectus Technologies Co., Ltd
  • Liferiver Bio-Tech Corp.
  • Molbio Diagnostics Pvt. Ltd.
  • MyBioSource
  • Pirbright researchers
  • YouSeq Ltd.
図表

LIST OF TABLES

  • 1. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL RT PCR BASED NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL ELISA BASED NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
  • 5. GLOBAL NIPAH VIRUS INFECTION TESTING BY BLOOD SERUM OR PLASMA SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL NIPAH VIRUS INFECTION TESTING BY SALIVA AND THROAT SWABS SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL NIPAH VIRUS INFECTION TESTING BY URINE SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL NIPAH VIRUS INFECTION TESTING BY OTHERS SAMPLE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 10. GLOBAL NIPAH VIRUS INFECTION TESTING FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL NIPAH VIRUS INFECTION TESTING FOR RESEARCH INSTITUTIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL NIPAH VIRUS INFECTION TESTING FOR DIAGNOSTIC CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL NIPAH VIRUS INFECTION TESTING FOR OTHERS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 19. EUROPEAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. EUROPEAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
  • 21. EUROPEAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
  • 22. EUROPEAN NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
  • 25. ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
  • 26. ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY TEST TYPE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY SAMPLE, 2022-2030 ($ MILLION)
  • 29. REST OF THE WORLD NIPAH VIRUS INFECTION TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET SHARE BY TEST TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL RT PCR BASED NIPAH VIRUS INFECTION TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL ELISA BASED NIPAH VIRUS INFECTION TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET SHARE BY SAMPLE, 2022 VS 2030 (%)
  • 5. GLOBAL NIPAH VIRUS INFECTION TESTING BY BLOOD SERUM OR PLASMA SAMPLE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL NIPAH VIRUS INFECTION TESTING BY SALIVA AND THROAT SWABS SAMPLE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL NIPAH VIRUS INFECTION TESTING BY URINE SAMPLE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL NIPAH VIRUS INFECTION TESTING BY OTHERS SAMPLE MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET SHARE BY END-USER, 2022 VS 2030 (%)
  • 10. GLOBAL NIPAH VIRUS INFECTION TESTING FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL NIPAH VIRUS INFECTION TESTING FOR RESEARCH INSTITUTIONS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL NIPAH VIRUS INFECTION TESTING FOR DIAGNOSTIC CENTERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL NIPAH VIRUS INFECTION TESTING FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. GLOBAL NIPAH VIRUS INFECTION TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 15. US NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. CANADA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. UK NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. FRANCE NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. GERMANY NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ITALY NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SPAIN NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF EUROPE NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. INDIA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. CHINA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. JAPAN NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. SOUTH KOREA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. LATIN AMERICA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. MIDDLE EAST AND AFRICA NIPAH VIRUS INFECTION TESTING MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027811

Title: Global Nipah Virus Infection Testing Market Size, Share & Trends Analysis Report by Test (RT PCR Based Kits, and ELISA Kits), by Sample (Blood Serum or Plasma, Saliva and Throat Swabs, Urine, and Others), and by End-User (Hospitals, Research Institutions, Diagnostic Centers, and Others),Forecast Period (2023-2030).

Global Nipah virus infection testing market is anticipated to grow at a CAGR of 4.8% during the Forecast Period (2023-2030). The market's growth is attributed to the growing incidence of Nipah virus infection across the globe. NiV can be passed from infected animals (such as pigs or bats) or their bodily fluids to individuals through contact. It involves fluids including blood, urine, and saliva. According to the National Institute of Health, in March 2023, Encephalitis and NiV infection are connected (inflammation of the brain). After exposure and a period lasting from 5 to 14 days, the illness starts with a fever and headache that persist for 3-14 days. Lethargy, disorientation, and confusion may then follow. Within 24-48 hours, these signs and symptoms may progress to a coma. Early in their infections, some individuals may experience respiratory issues, and 50% of those who exhibited severe neurological symptoms additionally had pulmonary symptoms. Transmission of NiV may occur through contact with infected animals such as pigs or bats, or their body fluids (such as saliva, urine, or blood). During the first recorded NiV outbreak, people contracted the virus through close contact with sick pigs. The NiV strain found during that outbreak seemed to have initially spread among bats, then to pigs, and finally to pig populations.

Segmental Outlook

The global Nipah virus infection testing market is segmented on the test type, sample, and end-user. Based on the test type, the market is sub-segmented into RT PCR-based kits, and ELISA Kits. Based on the sample, the market is sub-segmented into blood serum or plasma, saliva and throat swabs, urine, and others. Furthermore, based on the market is sub-segmented into hospitals, research institutions, diagnostic centers, and others.

The ELISA Kits Sub-Segment is Anticipated to Contribute Significantly to the Global Nipah Virus Infection Testing Market

Among the test types, the ELISA Kits sub-segment is expected to hold a considerable share of the global Nipah virus infection testing market. The segmental growth is attributed to the increasing ELISA testing adoption. There is potential for an expansion in the use of the tests in clinical and public health settings as ELISA has proven to be a viable technique for Nipah virus detection. Economical and effective diagnostic technologies such as ELISA can be utilized in large-scale epidemiological investigations. According to the National Institute of Health (gov.), in September 2022, ELISA is an effective, safe, and cost-efficient diagnostic tool that can be used to detect Nipah virus in large-scale epidemiological investigations. IgM and IgG ELISA tests can also help inform public health interventions. Furthermore, in comparison to a reference test from the Centers for Disease Control and Prevention (CDC), US, the developed anti-NiV IgM and IgG ELISAs demonstrated a specificity of 99.28% and a sensitivity of 100%. Anti-Nipah IgM and IgG ELISA assays showed 100% negative predictive value and 90% and 93.94% positive predictive value, respectively, with test accuracy of 99.33%.

Regional Outlook

The global Nipah virus infection testing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America).

The Asia-Pacific Region is Expected to Grow at a Significant CAGR in the Global Nipah Virus Infection Testing Market

Among all regions, the Asia-Pacific region is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the increasing demand for testing. The reported cases in Kerala emphasize the significance it is to having accurate and widely available diagnostic procedures for the Nipah virus. Testing for diagnosis, contact tracing, and epidemic management are all required after cases are confirmed.

According to the World Health Organization (WHO), in October 2023, since 12 September, 387 samples have been tested, resulting in six positive cases of Nipah virus infection and 381 negative samples. Furthermore, six laboratory-confirmed cases of Nipah virus infection, including two fatalities, were reported between September 12 and September 15, 2023, according to the Kerala State Government. Males between the ages of 9 and 45 were involved in every confirmed instance, which was recorded in Kerala's Kozhikode district.

Market Players Outlook

The major companies serving the Nipah virus infection testing market include: Creative Biogene, Jiangsu Bioperfectus Technologies Co., Ltd., Molbio Diagnostics Pvt. Ltd., and YouSeq Ltd. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in September 2023, Kerala received monoclonal antibodies from the Indian Council of Medical Research (ICMR) and to combat the ongoing Nipah virus outbreak, a mobile laboratory has been set up at the center of the state.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global Nipah virus infection testing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 1.1.1. Overview
    • 1.1.2. Financial Analysis
    • 1.1.3. SWOT Analysis
    • 1.1.4. Recent Developments
  • 1.2. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Nipah Virus Infection Testing Market by Test Type
    • 4.1.1. RT PCR based kits
    • 4.1.2. ELISA Kits
  • 4.2. Global Nipah Virus Infection Testing Market by Sample Type
    • 4.2.1. Blood Serum or Plasma
    • 4.2.2. Saliva and Throat Swabs
    • 4.2.3. Urine
    • 4.2.4. Others (Cerebrospinal Fluid (CSF), Respiratory Secretions, and Environmental Samples)
  • 4.3. Global Nipah Virus Infection Testing Market by End-User
    • 4.3.1. Hospitals
    • 4.3.2. Research Institutions
    • 4.3.3. Diagnostic Centers
    • 4.3.4. Others (Non-Governmental Organizations (NGOs), Emergency Response Teams, Public Health Authorities)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Creative Biogene.
  • 6.2. Creative Diagnostics
  • 6.3. Indian Council of Medical Research-National Institute of Virus
  • 6.4. Jiangsu Bioperfectus Technologies Co., Ltd
  • 6.5. Liferiver Bio-Tech Corp.
  • 6.6. Molbio Diagnostics Pvt. Ltd.
  • 6.7. MyBioSource
  • 6.8. Pirbright researchers
  • 6.9. YouSeq Ltd.